6th Annual World Drug Discovery & Development Summit, Cologne, Germany
Tuesday, December 05, 2006 - Wednesday, December 06, 2006
WDD 2006 features case studies from the worlds leading Pharma companies focusing on overcoming scientific and strategic challenges faced in the research and development process.
Topics to be discussed:
R&D; Success lessons to be learnt
Screening Strategy target based vs. phenotypic approaches
Biomarkers are biomarkers really the holy grail of drug discovery?
Alliances do early partnership offer the key to success in development?
Toxicity does early ADME/TOX screening reduce attrition rates?
Technology what is the future of R&D; technology and where is it leading?
- Prof. Ian Wilson, Senior Principal Scientist, AstraZeneca
- Dr Hanno Wild, Senior Vice President Discovery Europe, Pharma Global Drug Discovery, Bayer HealthCare AG
- Dr Graham Dixon, Senior Vice President, Drug Discovery, Galapagos NV
- Dr Frank Sams-Dodd, Vice President, Preclinical Development, Bionomics
For full programme details, speaker list, confirmed delegates and to register, please visit www.wddsummit.com
Further Information: http://www.wddsummit.com